3C
MRK icon

361 Capital’s Merck MRK Stock Holding History

361 Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,063
Closed -$1.11M – 362
2020
Q1 		$1.11M Buy
15,063
+2,582
+21% +$203K 0.5% 40
2019
Q4 		$1.08M Buy
12,481
+660
+6% +$54.2K 0.3% 209
2019
Q3 		$950K Sell
11,821
-94
-0.8% -$7.53K 0.18% 213
2019
Q2 		$953K Buy
+11,915
New +$912K 0.17% 213

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

361 Capital's MRK Position: Q2 2020 in Review

361 Capital sold out of Merck (MRK) in Q2 2020, closing a stake of 15,063 shares — an estimated $1.11M sold.

361 Capital first reported a position in MRK in Q2 2019 and held it in 4 quarters. The position peaked at $1.11M in Q1 2020. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • 361 Capital reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • 361 Capital sold 15,063 Merck shares in Q2 2020, an estimated $1.11M.
  • 361 Capital first reported a position in Merck in Q2 2019 and held it in 4 quarters.
  • 361 Capital's Merck position peaked at $1.11M in Q1 2020.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.